PING AN froze new US private market investments after Trump's April 2025 tariff hikes and has not resumed for more than 12 months, per Bloomberg sources. The Chinese insurer's pullback removes a significant source of Asian capital from US private equity and venture capital funds.
PING AN (02318.HK) froze new US private market investments after Trump's April 2025 tariff hikes and has not resumed, people familiar with the matter told Bloomberg.
The Chinese insurer stopped making new investment commitments in US private equity and venture capital funds following the Trump administration's sweeping tariff increases, the people said. The freeze has been in place for more than a year with no indication of when it might end.
PING AN shares rose 0.2% in Hong Kong trading Wednesday. The stock's short-selling ratio stood at 33.4%, exchange data show, reflecting bearish positioning by market participants. The Hang Seng Index was little changed on the day.
The pullback comes as other Asian institutional investors have grown cautious about US private markets. Investors have placed record short bets against the US stock market, according to exchange data compiled by Bloomberg. The S&P 500 has faced persistent selling pressure as trade uncertainty weighs on corporate earnings outlooks.
For PING AN, the freeze marks a strategic shift for one of China's largest financial conglomerates. The company had been an active participant in US private markets, allocating capital to top-tier private equity and venture capital firms. Its withdrawal removes a significant source of Asian capital from the US private fundraising ecosystem, which has already seen reduced inflows from Chinese investors since the tariff escalation.
The development shows how Trump's tariff policies continue to influence cross-border capital flows more than a year after their implementation. Other Chinese institutional investors, including insurers and sovereign wealth funds, may follow PING AN's lead, potentially reducing capital inflows into US private equity and venture capital funds that have relied on Asian limited partners for growth.
CMBI expects PING AN's second-quarter operating profit growth momentum to continue, though new business value growth may slow, analysts wrote in a recent note. The insurer is scheduled to report second-quarter results in August. Investors will watch for any resumption of US private market commitments as a gauge of improving trade relations between the world's two largest economies.
The freeze also highlights the broader impact of trade policy on institutional capital allocation. US private equity firms that count Chinese insurers among their limited partners may need to seek alternative sources of funding. For PING AN, the capital that would have gone to US private markets is likely being redeployed to domestic opportunities or other regions less affected by trade tensions.
This article is for informational purposes only and does not constitute investment advice.
